About Glucoset
Glucoset is a company based in Trondheim (Norway) founded in 2013 was acquired by Televenture in April 2015. Glucoset has raised $6.59 million across 8 funding rounds from investors including European Union, Norwegian Research Council and EIC Fund. The company has 20 employees as of December 31, 2022. Glucoset offers products and services including GlucoSet Sensor. Glucoset operates in a competitive market with competitors including Dexcom, Withings, Livongo, One Drop and Ultrahuman, among others.
- Headquarter Trondheim, Norway
- Employees 20 as on 31 Dec, 2022
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Glucoset As
-
Annual Revenue
$104.68 K (USD)374as on Dec 31, 2021
-
Net Profit
-$601.85 K (USD)-131as on Dec 31, 2022
-
EBITDA
-$474.9 K (USD)-170as on Dec 31, 2022
-
Total Equity Funding
$6.59 M (USD)
in 8 rounds
-
Latest Funding Round
$6.52 M (USD), Series A
Jul 07, 2023
-
Investors
European Union
& 4 more
-
Employee Count
20
as on Dec 31, 2022
-
Acquired by
Televenture
(Apr 09, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Glucoset
Glucoset offers a comprehensive portfolio of products and services, including GlucoSet Sensor.
Minimally invasive sensor for continuous blood glucose monitoring in ICU
Funding Insights of Glucoset
Glucoset has successfully raised a total of $6.59M across 8 strategic funding rounds. The most recent funding activity was a Series A round of $6.52 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Glucoset
Glucoset has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, Norwegian Research Council and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Investments are focused on diabetes technology startups worldwide.
|
Locked | Locked | Locked | |
|
Televenture is recognized as a leading venture capital firm in Norway.
|
Locked | Locked | Locked |
Investor details for Glucoset
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Glucoset
Investment portfolio details for Glucoset
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Glucoset
Detailed financials for Glucoset
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Glucoset Comparisons
Peer comparison for Glucoset
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Glucoset
Glucoset operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dexcom, Withings, Livongo, One Drop and Ultrahuman, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable glucose monitoring patches are provided for real-time data tracking.
|
|
| Locked | Locked | Locked |
Connected devices for health, sleep, and activity monitoring are developed.
|
|
| Locked | Locked | Locked |
Provider of smart devices for diabetes management for patients and doctors
|
|
| Locked | Locked | Locked |
Provider of workforce healthcare solutions
|
|
| Locked | Locked | Locked |
Metabolic health is tracked via devices and fitness platforms.
|
|
| Locked | Locked | Locked |
Health-tracking smart rings and biosensors are developed for biometric monitoring.
|
Detailed competitors of Glucoset
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Glucoset
Complete news archive for Glucoset
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Glucoset
Glucoset was founded in 2013 and raised its 1st funding round 3 years after it was founded.
Glucoset is headquartered in Trondheim, Norway. It is registered at Trondheim, Trøndelag, Norway.
Glucoset is a funded company, having raised a total of $6.59M across 8 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Glucoset is 20.
Annual revenue of Glucoset is $104.68K as on Dec 31, 2021.
Glucoset was founded in 2013 in Trondheim, Norway, and operates in the medical devices sector. Intravascular sensors for continuous blood glucose monitoring are produced, allowing access through existing arterial catheters without additional insertions or equipment displacement. Glucose levels are tracked in real time for patients, supporting level normalization. The sensors are designed for compatibility with patient movement and reduced cross-sectional area relative to alternatives.
Glucoset's top competitors include Withings, Ultrahuman and Oura.
Glucoset offers GlucoSet Sensor.
Glucoset has 5 investors. Key investors include European Union, Norwegian Research Council, EIC Fund, Diabetes Venture Fund, and Televenture.